August 19, 2019

ESC preview – Medicines Company hopes for a starring role

Novartis has been reduced to a Paragon data dredge, but results with The Medicines Company’s inclisiran, Astrazeneca’s Brilinta and Cellaegis’ AutoRIC device should pique…

May 21, 2018

Boston Scientific’s plan to keep the rhythm going

An acquisitive company has a plan for the future.

May 11, 2018

Ablation groups scramble to cope with Cabana

The Cabana trial has finally reported, but the data are inconclusive.

November 03, 2017

GeneSight trial miss leaves Myriad depressed

July 12, 2017

Vifor takes iron therapy expansion to heart

June 21, 2017

Smith & Nephew innovates in wound care, but no trade sale in sight

November 01, 2016

TCT 2016: Early clinical data back Medtronic’s inside-out stent

October 26, 2015

Interview – Xhale helps pharma breathe easy on compliance

September 09, 2015

Glaxo shoots itself in the foot... again